Biologics in oral medicine: Sjogren syndrome.

about

Orofacial adverse effects of biological agents.Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjögren syndrome patients: A case-control study.

P2860

Q38213692-A8BD6032-E007-4F3B-92E7-D367E3477BF0 Q55417704-85095DA4-3F25-41D8-81A6-F52D69BF6C24

P2860

Biologics in oral medicine: Sjogren syndrome.

Item

http://www.wikidata.org/entity/Q38002156

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Biologics in oral medicine: Sjogren syndrome.

@en

type

Item

label

Biologics in oral medicine: Sjogren syndrome.

@en

prefLabel

Biologics in oral medicine: Sjogren syndrome.

@en

P1476

Biologics in oral medicine: Sjogren syndrome

@en

P2093

C Scully

http://www.w3.org/2001/XMLSchema#string

P2860

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome.

The overlap of Sjögren's syndrome with other systemic autoimmune diseases.

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank.

Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries.

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

United Kingdom Primary Sjogren's Syndrome Registry--a united effort to tackle an orphan rheumatic disease.

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.

P304

121-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1601-0825.2012.01932.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Iain D O'Neill

P577

2012-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22497865

http://www.w3.org/2001/XMLSchema#string

Biologics in oral medicine: Sjogren syndrome.

about

P2860

P2860

Biologics in oral medicine: Sjogren syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698